Literature DB >> 27701042

Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.

M Eugenia Socías1, Evan Wood1, Will Small2, Huiru Dong3, Jean Shoveller4, Thomas Kerr1, Julio Montaner1, M-J Milloy5.   

Abstract

BACKGROUND: Methadone maintenance therapy (MMT) is associated with improved HIV treatment outcomes among people who use drugs (PWUD). The extent to which these benefits are sustained in the context of ongoing cocaine use is unclear. We assessed differential impacts of MMT on HIV viral load (VL) suppression in relation to discrete patterns of cocaine use.
METHODS: Data was drawn from ACCESS, a prospective cohort of HIV-positive PWUD in Vancouver, Canada. Generalized linear mixed-effects were used to model the independent effect of MMT on VL suppression across strata of frequency of cocaine injection and crack smoking (≥daily versus <daily), after adjustment for confounders.
RESULTS: The analysis included 397 HIV-positive opioid users who completed ≥1 study interview between 2005 and 2014. At baseline, 304 (77%) reported participation in MMT, 37 (9%) ≥daily cocaine injection, and 158 (40%) ≥daily crack smoking. In adjusted analyses, MMT remained independently associated with increased odds of VL suppression in both strata of crack smokers (AOR=3.11, 95% CI: 1.86-5.21 and AOR=1.48, 95%CI: 1.04-2.09, for ≥daily and <daily smokers, respectively), and among <daily cocaine injectors (AOR=1.88, 95%CI 1.38-2.56), but not among ≥daily cocaine injectors (AOR=1.37, 95%CI 0.53-3.49). Longer retention on MMT was positively associated with VL suppression in all strata of cocaine injection and crack smoke.
CONCLUSIONS: Exposure to MMT was associated with increased odds of VL suppression among HIV- positive opioid users regardless of crack use. However, this beneficial effect of MMT was lost among frequent cocaine injectors with shorter retention on MMT.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antiretroviral therapy; Cocaine; Methadone maintenance therapy; Opioid substitution treatment; Opioid use disorder; Viral suppression

Mesh:

Substances:

Year:  2016        PMID: 27701042      PMCID: PMC5257247          DOI: 10.1016/j.drugalcdep.2016.09.013

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  44 in total

1.  Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women.

Authors:  Tanya Telfair Sharpe; Lisa M Lee; Allyn K Nakashima; Laurie D Elam-Evans; Patricia L Fleming
Journal:  J Community Health       Date:  2004-04

2.  Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users.

Authors:  Thomas Kerr; Brandon D L Marshall; M-J Milloy; Ruth Zhang; Silvia Guillemi; Julio S G Montaner; Evan Wood
Journal:  Drug Alcohol Depend       Date:  2012-01-14       Impact factor: 4.492

Review 3.  Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy.

Authors:  Daryl Shorter; Coreen B Domingo; Thomas R Kosten
Journal:  Expert Opin Emerg Drugs       Date:  2014-11-26       Impact factor: 4.191

4.  The validity of drug users' self-reports in a non-treatment setting: prevalence and predictors of incorrect reporting methadone treatment modalities.

Authors:  M W Langendam; H J van Haastrecht; E J van Ameijden
Journal:  Int J Epidemiol       Date:  1999-06       Impact factor: 7.196

Review 5.  Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission.

Authors:  Judith A Cook
Journal:  Life Sci       Date:  2011-01-08       Impact factor: 5.037

6.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

7.  Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment.

Authors:  Adam Gonzalez; Matthew J Mimiaga; Jared Israel; C Andres Bedoya; Steven A Safren
Journal:  AIDS Behav       Date:  2013-01

8.  Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia.

Authors:  Benedikt Fischer; Jeff Powis; Michelle Firestone Cruz; Katherine Rudzinski; Jürgen Rehm
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-01       Impact factor: 2.566

9.  Cocaine use and risky injection and sexual behaviors.

Authors:  R Hudgins; J McCusker; A Stoddard
Journal:  Drug Alcohol Depend       Date:  1995-01       Impact factor: 4.492

10.  Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis.

Authors:  Pouya Azar; Evan Wood; Paul Nguyen; Maxo Luma; Julio Montaner; Thomas Kerr; M-J Milloy
Journal:  BMC Infect Dis       Date:  2015-04-18       Impact factor: 3.090

View more
  12 in total

1.  Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial.

Authors:  Evgeny Krupitsky; Elena Blokhina; Edwin Zvartau; Elena Verbitskaya; Dmitri Lioznov; Tatiana Yaroslavtseva; Vladimir Palatkin; Marina Vetrova; Natalia Bushara; Andrei Burakov; Dmitri Masalov; Olga Mamontova; Daniel Langleben; Sabrina Poole; Robert Gross; George Woody
Journal:  Lancet HIV       Date:  2019-03-14       Impact factor: 12.767

2.  Longitudinal Factors Associated with Used Syringe Lending Among HIV-Positive Antiretroviral Therapy-Naïve People Who Inject Drugs in a Canadian Setting.

Authors:  Ezequiel Blumenkrans; M Eugenia Socías; Lindsey Richardson; Thomas Kerr; Jean Shoveller; Julio Montaner; M-J Milloy
Journal:  AIDS Behav       Date:  2020-07

3.  Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).

Authors:  Roman Shrestha; Michael M Copenhaver
Journal:  Addict Behav       Date:  2018-05-31       Impact factor: 3.913

4.  Opioid agonist treatment improves progression through the HIV cascade of care among people living with HIV who use unregulated opioids.

Authors:  Stephen Juwono; M-J Milloy; JinCheol Choi; Nadia Fairbairn; Seonaid Nolan; M Eugenia Socías
Journal:  AIDS       Date:  2022-05-25       Impact factor: 4.632

5.  HIV-Related Stigma, Motivation to Adhere to Antiretroviral Therapy, and Medication Adherence Among HIV-Positive Methadone-Maintained Patients.

Authors:  Roman Shrestha; Frederick L Altice; Michael M Copenhaver
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

6.  Implementation of methadone therapy for opioid use disorder in Russia - a modeled cost-effectiveness analysis.

Authors:  Bulat Idrisov; Sean M Murphy; Tyler Morrill; Mayada Saadoun; Karsten Lunze; Donald Shepard
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-01-20

7.  Sexual behaviors among methadone maintenance patients in a mountainous area in northern Vietnam.

Authors:  Victoria L Boggiano; Huong Lan Thi Nguyen; Long Hoang Nguyen; Tho Dinh Tran; Hung Van Nguyen; Huong Thi Le; Hai Quan Le; Canh Dinh Hoang; Cuong Tat Nguyen; Bach Xuan Tran; Carl A Latkin; Nabil Zary; Thuc Minh Thi Vu
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-08-25

Review 8.  Associated Factors of Maintenance in Patients under Treatment with Methadone: A Comprehensive Systematic Review and Meta-Analysis.

Authors:  Farzaneh Farmani; Hadi Farhadi; Younes Mohammadi
Journal:  Addict Health       Date:  2018-01

Review 9.  A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease Outcomes.

Authors:  Katelyn F McNamara; Breanne E Biondi; Raúl U Hernández-Ramírez; Noor Taweh; Alyssa A Grimshaw; Sandra A Springer
Journal:  Open Forum Infect Dis       Date:  2021-06-02       Impact factor: 3.835

10.  Social-demographic shift in drug users at the first-ever- methadone maintenance treatment in Wuhan, China.

Authors:  Cong Liu; Pu-Lin Liu; Quan-Lin Dong; Li Luo; Jun Xu; Wang Zhou; Xia Wang
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.